Urinary concentration: Different ways to open and close the tap

Pediatric Nephrology

Volumn 29, Issue 8, 2014, Pages 1297-1303

  Bockenhauer, Detlef ^a   Bichet, Daniel G ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

AQP2; AVPR2; cAMP; Collecting duct; Kidney; Nephrogenic diabetes insipidus; Prostaglandins; Thirst

Indexed keywords

AQUAPORIN 2; CALCIUM SENSING RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDOMETACIN; LITHIUM; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN; PROSTAGLANDIN RECEPTOR AFFECTING AGENT; SECRETIN; THIAZIDE DIURETIC AGENT; VASOPRESSIN RECEPTOR; VASOPRESSIN V2 RECEPTOR; WATER;

CLINICAL FEATURE; DIET THERAPY; HOMEOSTASIS; HUMAN; HYPOKALEMIA; KIDNEY CONCENTRATING CAPACITY; NEPHROGENIC DIABETES INSIPIDUS; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; WATER PERMEABILITY; BODY WATER; CHILD; GENETICS; METABOLISM; URINE;

BODY WATER; CHILD; DIABETES INSIPIDUS, NEPHROGENIC; HUMANS; KIDNEY CONCENTRATING ABILITY;

EID: 84903794641     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-013-2526-4     Document Type: Review

References (56)

1. McIlraith CH (1892) Notes on some cases of diabetes insipidus with marked family and hereditary tendencies. Lancet 2:767
2. de Lange C (1935) Ueber erblichen Diabetes Insipidus. Jahrbuch fuer Kinderheilkunde 145:135
3. Williams RhH C (1947) Nephrogenic diabetes insipidus: transmitted by females and appearing during infancy in males. Ann Intern Med 27:84-95
4. Lolait SJ, O'Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ (1992) Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336-339
5. Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy GN, Birnbaumer M, Bichet DG (1992) Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359:233-235
6. van den Ouweland AM, Dreesen JC, Verdijk M, Knoers NV, Monnens LA, Rocchi M, van Oost BA (1992) Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet 2:99-102
7. Pan Y, Metzenberg A, Das S, Jing B, Gitschier J (1992) Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat Genet 2:103-106
8. Fushimi K, Uchida S, Hara Y, Hirata Y, Marumo F, Sasaki S (1993) Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature 361:549-552 (Pubitemid 23055619)
9. Sasaki S, Fushimi K, Saito H, Saito F, Uchida S, Ishibashi K, Kuwahara M, Ikeuchi T, Inui K, Nakajima K (1994) Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct. J Clin Invest 93:1250-1256 (Pubitemid 24087181)
10. Deen PM, Verdijk MA, Knoers NV, Wieringa B, Monnens LA, van Os CH, van Oost BA (1994) Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264:92-95 (Pubitemid 24144492)
11. Lemmens-Gruber R, Kamyar M (2006) Vasopressin antagonists. Cell Mol Life Sci 63:1766-1779 (Pubitemid 44223085)
12. Bockenhauer D, Aitkenhead H (2011) The kidney speaks: interpreting urinary sodium and osmolality. Arch Dis Child Educ Pract Ed 96:223-227
13. Prager-Khoutorsky M, Bourque CW (2010) Osmosensation in vasopressin neurons: changing actin density to optimize function. Trends Neurosci 33:76-83
14. McKinley MJ, Denton DA, Oldfield BJ, De Oliveira LB, Mathai ML (2006) Water intake and the neural correlates of the consciousness of thirst. Semin Nephrol 26:249-257
15. Bichet DG, Razi M, Lonergan M, Arthus MF, Papukna V, Kortas C, Barjon JN (1988) Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 318:881-887 (Pubitemid 18090272)
16. Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA (2002) Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82:205-244 (Pubitemid 34654219)
17. Raychowdhury MK, Ramos AJ, Zhang P, McLaughin M, Dai XQ, Chen XZ, Montalbetti N, Del Rocio CM, Ausiello DA, Cantiello HF (2009) Vasopressin receptor-mediated functional signaling pathway in primary cilia of renal epithelial cells. Am J Physiol Renal Physiol 296:F87-F97
18. Marion V, Schlicht D, Mockel A, Caillard S, Imhoff O, Stoetzel C, van Dijk P, Brandt C, Moulin B, Dollfus H (2011) Bardet-Biedl syndrome highlights the major role of the primary cilium in efficient water reabsorption. Kidney Int 79:1013-1025
19. Verkman AS (2002) Renal concentrating and diluting function in deficiency of specific aquaporin genes. Exp Nephrol 10:235-240
20. Sands JM, Naruse M, Baum M, Jo I, Hebert SC, Brown EM, Harris HW (1997) Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 99:1399-1405 (Pubitemid 27142778)
21. Bockenhauer D, Cruwys M, Kleta R, Halperin LF, Wildgoose P, Souma T, Nukiwa N, Cheema-Dhadli S, Chong CK, Kamel KS, Davids MR, Halperin ML (2008) Antenatal Bartter's syndrome: why is this not a lethal condition? QJM 101:927-942
22. Bockenhauer D, van't Hoff W, Dattani M, Lehnhardt A, Subtirelu M, Hildebrandt F, Bichet DG (2010) Secondary nephrogenic diabetes insipidus as a complication of inherited renal diseases. Nephron Physiology 116:p23-p29
23. Bockenhauer D, Bichet DG (2013) Inherited secondary nephrogenic diabetes insipidus: concentrating on humans. Am J Physiol Renal Physiol 304:p1037-1042
24. Lam GS, Asplin JR, Halperin ML (2000) Does a high concentration of calcium in the urine cause an important renal concentrating defect in human subjects? Clin Sci (Lond) 98:313-319 (Pubitemid 30145238)
25. Trimble ER, Bruzzone R, Biden TJ, Meehan CJ, Andreu D, Merrifield RB (1987) Secretin stimulates cyclic AMP and inositol trisphosphate production in rat pancreatic acinar tissue by two fully independent mechanisms. Proc Natl Acad Sci USA 84:3146-3150 (Pubitemid 17085361)
26. Chu JY, Chung SC, Lam AK, Tam S, Chung SK, Chow BK (2007) Phenotypes developed in secretin receptor-null mice indicated a role for secretin in regulating renal water reabsorption. Mol Cell Biol 27:2499-2511 (Pubitemid 46581342)
27. Cheng CY, Chu JY, Chow BK (2009) Vasopressin-independent mechanisms in controlling water homeostasis. J Mol Endocrinol 43:81-92
28. Marples D, Frokiaer J, Dorup J, Knepper MA, Nielsen S (1996) Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest 97:1960-1968 (Pubitemid 26129884)
29. Trepiccione F, Christensen BM (2010) Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings. J Nephrol 23(Suppl 16):S43-S48
30. Kortenoeven ML, Pedersen NB, Miller RL, Rojek A, Fenton RA (2013) Genetic ablation of aquaporin-2 in the mouse connecting tubules results in defective renal water handling. J Physiol 591:2205-2219
31. Handler JS (1981) Vasopressin-prostaglandin interactions in the regulation of epithelial cell permeability to water. Kidney Int 19:831-838
32. Gross PA, Schrier RW, Anderson RJ (1981) Prostaglandins and water metabolism: a review with emphasis on in vivo studies. Kidney Int 19:839-850 (Pubitemid 11095764)
33. Olesen ET, Rutzler MR, Moeller HB, Praetorius HA, Fenton RA (2011) Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus. Proc Natl Acad Sci USA 108:12949-12954
34. Li JH, Chou CL, Li B, Gavrilova O, Eisner C, Schnermann J, Anderson SA, Deng CX, Knepper MA, Wess J (2009) A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus. J Clin Invest 119:3115-3126
35. Bockenhauer D, Carpentier E, Rochdi D, Van't Hoff W, Breton B, Bernier V, Bouvier M, Bichet DG (2009) Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus. Nephron Physiol 114:p1-p10
36. Ala Y, Morin D, Mouillac B, Sabatier N, Vargas R, Cotte N, Dechaux M, Antignac C, Arthus MF, Lonergan M, Turner MS, Balestre MN, Alonso G, Hibert M, Barberis C, Hendy GN, Bichet DG, Jard S (1998) Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol 9:1861-1872
37. Jaureguiberry G, Van't Hoff W, Mushtaq I, Desai D, Mann NP, Kleta R, Bichet DG, Bockenhauer D (2011) A patient with polyuria and hydronephrosis: question. Pediatr Nephrol 26(1977-1978):1979-1980
38. Hoekstra JA, van Lieburg AF, Monnens LA, Hulstijn-Dirkmaat GM, Knoers VV (1996) Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet 61:81-88
39. van Lieburg AF, Knoers NV, Monnens LA (1999) Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 10:1958-1964
40. Coleman J (2001) Diseases of organ system: the kidney. In: Shaw V, Lawson M (eds) Clinical paediatric dietetics. Blackwell Science Ltd, Oxford
41. Kennedy GC, Crawford JD (1959) Treatment of diabetes insipidus with hydrochlorothiazide. Lancet 1:866-867
42. Crawford JD, Kennedy GC (1959) Chlorothiazid in diabetes insipidus. Nature 183:891-892
43. Bockenhauer D (2008) Diabetes insipidus. In: Geary DF, Schaefer F (eds) Comprehensive pediatric nephrology. Mosby Elsevier, Philadelphia, pp 489-498
44. Kramer HJ, Glanzer K, Dusing R (1981) Role of prostaglandins in the regulation of renal water excretion. Kidney Int 19:851-859 (Pubitemid 11095765)
45. Blachar Y, Zadik Z, Shemesh M, Kaplan BS, Levin S (1980) The effect of inhibition of prostaglandin synthesis on free water and osmolar clearances in patients with hereditary nephrogenic diabetes insipidus. Int J Pediatr Nephrol 1:48-52 (Pubitemid 10090180)
46. Usberti M, Dechaux M, Guillot M, Seligmann R, Pavlovitch H, Loirat C, Sachs C, Broyer M (1980) Renal prostaglandin E2 in nephrogenic diabetes insipidus: effects of inhibition of prostaglandin synthesis by indomethacin. J Pediatr 97:476-478 (Pubitemid 11225865)
47. Monnens L, Jonkman A, Thomas C (1984) Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus. Clin Sci (Lond) 66:709-715 (Pubitemid 14145926)
48. Kokko JP (1981) Effect of prostaglandins on renal epithelial electrolyte transport. Kidney Int 19:791-796
49. Bernier V, Morello JP, Zarruk A, Debrand N, Salahpour A, Lonergan M, Arthus MF, Laperriere A, Brouard R, Bouvier M, Bichet DG (2006) Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 17:232-243
50. Morello JP, Bichet DG (2001) Nephrogenic diabetes insipidus. Annu Rev Physiol 63:607-630
51. Morello JP, Salahpour A, Laperriere A, Bernier V, Arthus MF, Lonergan M, Petaja-Repo U, Angers S, Morin D, Bichet DG, Bouvier M (2000) Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 105:887-895 (Pubitemid 30203061)
52. Tamma G, Klussmann E, Oehlke J, Krause E, Rosenthal W, Svelto M, Valenti G (2005) Actin remodeling requires ERM function to facilitate AQP2 apical targeting. J Cell Sci 118:3623-3630 (Pubitemid 41309409)
53. Li W, Zhang Y, Bouley R, Chen Y, Matsuzaki T, Nunes P, Hasler U, Brown D, Lu HA (2011) Simvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase. Am J Physiol Renal Physiol 301:F309-F318
54. Homma S, Gapstur SM, Coffey A, Valtin H, Dousa TP (1991) Role of cAMP-phosphodiesterase isozymes in pathogenesis of murine nephrogenic diabetes insipidus. Am J Physiol 261:F345-F353
55. Bichet DG, Ruel N, Arthus MF, Lonergan M (1990) Rolipram, a phosphodiesterase inhibitor, in the treatment of two male patients with congenital nephrogenic diabetes insipidus. Nephron 56:449-450 (Pubitemid 20376484)
56. Sohara E, Rai T, Yang SS, Uchida K, Nitta K, Horita S, Ohno M, Harada A, Sasaki S, Uchida S (2006) Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation. Proc Natl Acad Sci USA 103:14217-14222 (Pubitemid 44453006)